BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 28723694)

  • 21. Single-Exosome-Counting Immunoassays for Cancer Diagnostics.
    Liu C; Xu X; Li B; Situ B; Pan W; Hu Y; An T; Yao S; Zheng L
    Nano Lett; 2018 Jul; 18(7):4226-4232. PubMed ID: 29888919
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of a Microfluidic Device for Exosome Isolation in Point-of-Care Settings.
    Ramnauth N; Neubarth E; Makler-Disatham A; Sher M; Soini S; Merk V; Asghar W
    Sensors (Basel); 2023 Oct; 23(19):. PubMed ID: 37837121
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging technologies and commercial products in exosome-based cancer diagnosis and prognosis.
    Mohammadi M; Zargartalebi H; Salahandish R; Aburashed R; Wey Yong K; Sanati-Nezhad A
    Biosens Bioelectron; 2021 Jul; 183():113176. PubMed ID: 33845291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exosomal microRNAs in liquid biopsies: future biomarkers for prostate cancer.
    Valentino A; Reclusa P; Sirera R; Giallombardo M; Camps C; Pauwels P; Crispi S; Rolfo C
    Clin Transl Oncol; 2017 Jun; 19(6):651-657. PubMed ID: 28054319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Towards Microfluidic-Based Exosome Isolation and Detection for Tumor Therapy.
    Wang J; Ma P; Kim DH; Liu BF; Demirci U
    Nano Today; 2021 Apr; 37():. PubMed ID: 33777166
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of tissue tropism and biological activity of exosomes and other extracellular vesicles: New nanotools for cancer treatment.
    Kooijmans SAA; Schiffelers RM; Zarovni N; Vago R
    Pharmacol Res; 2016 Sep; 111():487-500. PubMed ID: 27394168
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ultrasensitive detection of circulating exosomes with a 3D-nanopatterned microfluidic chip.
    Zhang P; Zhou X; He M; Shang Y; Tetlow AL; Godwin AK; Zeng Y
    Nat Biomed Eng; 2019 Jun; 3(6):438-451. PubMed ID: 31123323
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Microfluidic Approaches for Affinity-Based Exosome Separation.
    Theel EK; Schwaminger SP
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microfluidics for exosome isolation and analysis: enabling liquid biopsy for personalized medicine.
    Contreras-Naranjo JC; Wu HJ; Ugaz VM
    Lab Chip; 2017 Oct; 17(21):3558-3577. PubMed ID: 28832692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosomes as a liquid biopsy for lung cancer.
    Cui S; Cheng Z; Qin W; Jiang L
    Lung Cancer; 2018 Feb; 116():46-54. PubMed ID: 29413050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exosome Biochemistry and Advanced Nanotechnology for Next-Generation Theranostic Platforms.
    Yang B; Chen Y; Shi J
    Adv Mater; 2019 Jan; 31(2):e1802896. PubMed ID: 30126052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Microfluidic Technology for the Isolation and Analysis of Exosomes.
    Wu Y; Wang Y; Lu Y; Luo X; Huang Y; Xie T; Pilarsky C; Dang Y; Zhang J
    Micromachines (Basel); 2022 Sep; 13(10):. PubMed ID: 36295924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosomes as Theranostics for Lung Cancer.
    Srivastava A; Amreddy N; Razaq M; Towner R; Zhao YD; Ahmed RA; Munshi A; Ramesh R
    Adv Cancer Res; 2018; 139():1-33. PubMed ID: 29941101
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of size-selective microfluidic platform.
    Chen Z; Yamaguchi H; Kameoka J
    Annu Int Conf IEEE Eng Med Biol Soc; 2019 Jul; 2019():5661-5664. PubMed ID: 31947137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microfluidics-Based Urine Biopsy for Cancer Diagnosis: Recent Advances and Future Trends.
    Wang Y; Gao Y; Song Y
    ChemMedChem; 2022 Oct; 17(20):e202200422. PubMed ID: 36040297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exosomes in Cancer Disease.
    Zöller M
    Methods Mol Biol; 2016; 1381():111-49. PubMed ID: 26667458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated microfluidic-SERS for exosome biomarker profiling and osteosarcoma diagnosis.
    Han Z; Peng X; Yang Y; Yi J; Zhao D; Bao Q; Long S; Yu SX; Xu XX; Liu B; Liu YJ; Shen Y; Qiao L
    Biosens Bioelectron; 2022 Dec; 217():114709. PubMed ID: 36115123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nickel-Doped Microfluidic Chip for Rapid and Efficient Immunomagnetic Separation and Detection of Breast Cancer Cell-Derived Exosomes.
    Fang H; Liu M; Jiang W
    Appl Biochem Biotechnol; 2023 May; 195(5):3109-3121. PubMed ID: 36542270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microfluidic-based capture and release of cancer-derived exosomes via peptide-nanowire hybrid interface.
    Suwatthanarak T; Thiodorus IA; Tanaka M; Shimada T; Takeshita D; Yasui T; Baba Y; Okochi M
    Lab Chip; 2021 Feb; 21(3):597-607. PubMed ID: 33367429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biogenesis, Isolation, and Detection of Exosomes and Their Potential in Therapeutics and Diagnostics.
    Sonbhadra S; Mehak ; Pandey LM
    Biosensors (Basel); 2023 Aug; 13(8):. PubMed ID: 37622888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.